Skip Header

 
Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot P07861 (NEP_RAT)

Last modified June 16, 2009. Version 89. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (2) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Neprilysin
    EC=3.4.24.11
Alternative name(s):
    Neutral endopeptidase 24.11
      Short name=Neutral endopeptidase
      Short name=NEP
    Enkephalinase
    Atriopeptidase
    CD_antigen=CD10
Gene names
Name: Mme
OrganismRattus norvegicus (Rat)
Taxonomic identifier10116 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresGliresRodentiaSciurognathiMuroideaMuridaeMurinaeRattus

Protein attributes

Sequence length750 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Thermolysin-like specificity, but is almost confined on acting on polypeptides of up to 30 amino acids. Biologically important in the destruction of opioid peptides such as Met- and Leu-enkephalins by cleavage of a Gly-Phe bond. Involved in the degradation of atrial natriuretic factor (ANF).

Catalytic activity

Preferential cleavage of polypeptides between hydrophobic residues, particularly with Phe or Tyr at P1'.

Cofactor

Binds 1 zinc ion per subunit.

Enzyme regulation

Inhibited in a dose dependent manner by sialorphin.

Subcellular location

Cell membrane; Single-pass type II membrane protein.

Sequence similarities

Belongs to the peptidase M13 family.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Initiator methionine11Removed
Chain2 – 750749Neprilysin
PRO_0000078217

Regions

Topological domain2 – 2827Cytoplasmic Potential
Transmembrane29 – 5123Signal-anchor for type II membrane protein Potential
Topological domain52 – 750699Extracellular Potential
Motif16 – 238Stop-transfer sequence Potential

Sites

Active site5851 By similarity
Active site6511Proton donor By similarity
Metal binding5841Zinc; catalytic By similarity
Metal binding5881Zinc; catalytic By similarity
Metal binding6471Zinc; catalytic By similarity
Binding site1031Substrate carboxyl

Amino acid modifications

Glycosylation1451N-linked (GlcNAc...) By similarity
Glycosylation2111N-linked (GlcNAc...) Potential
Glycosylation2851N-linked (GlcNAc...) Potential
Glycosylation3111N-linked (GlcNAc...) Ref.1
Glycosylation3251N-linked (GlcNAc...) By similarity
Glycosylation6281N-linked (GlcNAc...) By similarity
Disulfide bond57 ↔ 62 By similarity
Disulfide bond80 ↔ 735 By similarity
Disulfide bond88 ↔ 695 By similarity
Disulfide bond143 ↔ 411 By similarity
Disulfide bond234 ↔ 242 By similarity
Disulfide bond621 ↔ 747 By similarity

Sequences

Sequence LengthMass (Da)Tools
P07861-1 [UniParc].

Last modified January 23, 2007. Version 2.
Checksum: 609D4716C4B15CBC

FASTA75085,795
        10         20         30         40         50         60 
MGRSESQMDI TDINAPKPKK KQRWTPLEIS LSVLVLLLTI IAVTMIALYA TYDDGICKSS 

        70         80         90        100        110        120 
DCIKSAARLI QNMDASAEPC TDFFKYACGG WLKRNVIPET SSRYSNFDIL RDELEVILKD 

       130        140        150        160        170        180 
VLQEPKTEDI VAVQKAKTLY RSCINESAID SRGGQPLLTL LPDIYGWPVA SQNWEQTYGT 

       190        200        210        220        230        240 
SWTAEKSIAQ LNSKYGKKVL INFFVGTDDK NSTQHIIHFD QPRLGLPSRD YYECTGIYKE 

       250        260        270        280        290        300 
ACTAYVDFMI SVARLIRQEQ RLPIDENQLS LEMNKVMELE KEIANATTKP EDRNDPMLLY 

       310        320        330        340        350        360 
NKMTLAKLQN NFSLEINGKP FSWSNFTNEI MSTVNINIQN EEEVVVYAPE YLTKLKPILT 

       370        380        390        400        410        420 
KYSPRDLQNL MSWRFIMDLV SSLSRNYKES RNAFRKALYG TTSETATWRR CANYVNGNME 

       430        440        450        460        470        480 
NAVGRLYVEA AFAGESKHVV EDLIAQIREV FIQTLDDLTW MDAETKKKAE EKALAIKERI 

       490        500        510        520        530        540 
GYPDDIISNE NKLNNEYLEL NYKEEEYFEN IIQNLKFSQS KQLKKLREKV DKDEWISGAA 

       550        560        570        580        590        600 
VVNAFYSSGR NQIVFPAGIL QPPFFSARQS NSLNYGGIGM VIGHEITHGF DDNGRNFNKD 

       610        620        630        640        650        660 
GDLVDWWTQQ SANNFKDQSQ CMVYQYGNFT WDLAGGQHLN GINTLGENIA DNGGIGQAYR 

       670        680        690        700        710        720 
AYQNYVKKNG EEKLLPGLDL NHKQLFFLNF AQVWCGTYRP EYAVNSIKTD VHSPGNFRII 

       730        740        750 
GTLQNSAEFA DAFHCRKNSY MNPERKCRVW 

« Hide

References

« Hide 'large scale' references
[1]"Molecular cloning and amino acid sequence of rat enkephalinase."
Malfroy B., Schofield P.R., Kuang W.-J., Seeburg P.H., Mason A.J., Henzel W.J.
Biochem. Biophys. Res. Commun. 144:59-66(1987) [PubMed: 3555489] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE.
[2]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Kidney.
[3]"Identification of the active-site arginine in rat neutral endopeptidase 24.11 (enkephalinase) as arginine 102 and analysis of a glutamine 102 mutant."
Bateman R.C. Jr., Jackson D., Slaughter C.A., Unnithan S., Chai Y.G., Moomaw C., Hersh L.B.
J. Biol. Chem. 264:6151-6157(1989) [PubMed: 2703483] [Abstract]
Cited for: ACTIVE SITE ARG-103.
[4]"Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity."
Rougeot C., Messaoudi M., Hermitte V., Rigault A.G., Blisnick T., Dugave C., Desor D., Rougeon F.
Proc. Natl. Acad. Sci. U.S.A. 100:8549-8554(2003) [PubMed: 12835417] [Abstract]
Cited for: INHIBITION BY SIALORPHIN.

Cross-references

Sequence databases

M15944 mRNA. Translation: AAA41116.1.
BC085753 mRNA. Translation: AAH85753.1.
IPIIPI00231789.
PIRHYRTN. A29295.
RefSeqNP_036740.1.
UniGeneRn.33598

3D structure databases

HSSPHSSP built from PDB template 1DMT based on UniProtKB P08473.
SMRP07861. Positions 55-750.
ModBaseSearch...

Protein family/group databases

MEROPSM13.001.

Proteomic databases

PRIDEP07861.

Genome annotation databases

EnsemblENSRNOG00000009514. Rattus norvegicus. [Contig view]
GeneID24590.
KEGGrno:24590.

Organism-specific databases

RGD3098. Mme.

Phylogenomic databases

HOVERGENP07861.
OMAP07861. GRNQIVF.

Enzyme and pathway databases

BRENDA3.4.24.11. 248.

Gene expression databases

ArrayExpressP07861.
GermOnlineENSRNOG00000009514. Rattus norvegicus.

Family and domain databases

InterProIPR006025. Pept_M_Zn_BS.
IPR000718. Peptidase_M13.
IPR018497. Peptidase_M13_C.
IPR008753. Peptidase_M13_N.
[Graphical view]
PANTHERPTHR11733. Peptidase_M13. 1 hit.
PfamPF01431. Peptidase_M13. 1 hit.
PF05649. Peptidase_M13_N. 1 hit.
[Graphical view]
PRINTSPR00786. NEPRILYSIN.
PROSITEPS00142. ZINC_PROTEASE. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio603776.

Entry information

Entry nameNEP_RAT
AccessionPrimary (citable) accession number: P07861
Entry history
Integrated into UniProtKB/Swiss-Prot: August 1, 1988
Last sequence update: January 23, 2007
Last modified: June 16, 2009
This is version 89 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

Peptidase families

Classification of peptidase families and list of entries

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents